Compare PDSB & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PDSB | NTWK |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | United States |
| Employees | 10 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.5M | 39.7M |
| IPO Year | 2015 | 1997 |
| Metric | PDSB | NTWK |
|---|---|---|
| Price | $0.54 | $3.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 355.1K | 27.5K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.90 | ★ 316.67 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $73,088,687.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 13.40 |
| 52 Week Low | $0.52 | $2.14 |
| 52 Week High | $1.90 | $5.75 |
| Indicator | PDSB | NTWK |
|---|---|---|
| Relative Strength Index (RSI) | 38.86 | 39.83 |
| Support Level | $0.52 | $2.87 |
| Resistance Level | $1.16 | $3.70 |
| Average True Range (ATR) | 0.06 | 0.16 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 18.23 | 0.00 |
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.